Regular market approval granted for vaccines

India’s drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said on Thursday.

migrator

Published:28th Jan, 2022 at 3:43 AM

New Delhi

India’s drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said on Thursday. The Minister also said that the government’s vaccination drive will continue as it is to provide first and second doses for all and a precautionary dose for senior citizens with co-morbidities as well as for frontline workers.

Visit news.dtnext.in to explore our interactive epaper!

Download the DT Next app for more exciting features!

Click here for iOS

Click here for Android

Regular market approval granted for vaccines

India’s drug regulator has granted regular market approval for COVID-19 vaccines Covishield and Covaxin for use in the adult population subject to certain conditions, Health Minister Mansukh Mandaviya said on Thursday.

Also Read

DMK will stage 'drama' as its dream of coming to power with 'bogus' votes shattered: Palaniswami

8 elephants killed after being hit by Sairang-New Delhi Rajdhani Exp in Assam's Hojai dist: Official

SIR: 1 in 3 voters axed from Chennai's draft electoral roll

Draft roll released; how to find your details, what to do if name not found

Noted Malayalam actor-screenwriter Sreenivasan dies at 69